Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Improvement of the pharmacological properties of amidated kyotorphin by means of iodination
Publication

Publications

Improvement of the pharmacological properties of amidated kyotorphin by means of iodination

Title
Improvement of the pharmacological properties of amidated kyotorphin by means of iodination
Type
Article in International Scientific Journal
Year
2016
Authors
Oliveira, MC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gano, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Santos, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Correia, JDG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Serrano, ID
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Santos, SS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ribeiro, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Perazzo, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Isaura Tavares
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Heras, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bardaji, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Castanho, MA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: MedChemCommImported from Authenticus Search for Journal Publications
Vol. 7
Pages: 906-913
ISSN: 2040-2503
Other information
Authenticus ID: P-00K-GVV
Abstract (EN): Amidated kyotorphin (L-Tyr-L-Arg-NH2; KTP-NH2) shows analgesic properties following systemic administration. Although KTP-NH2 does not have toxic effects in the liver, its biodistribution is unknown. KTP-NH2 was radioiodinated to evaluate its biological fate in vivo. Mono-radioiodinated KTP-NH2 ([I-125]MIK) was radiochemically stable in vitro, namely in saline at 4 degrees C up to 1 week, and moderately stable when incubated with human serum at 37 degrees C. Although the radioiodinated peptide could translocate a cellular model of the blood-brain barrier (BBB), the levels of radioactivity in the brain were minimal, 5 and 10 min after intraperitoneal injection (i.p.). Significant accumulation of I-125 was found in the thyroid probably reflecting the hydrolysis of the iodine-tyrosine bond by liver deiodinases. HPLC analysis of plasma samples collected 5 min post-injection showed that intact [I-125]MIK accounted for 72.5% of the total radioactivity, whereas the remaining radioactivity was associated with free radioiodide (I-). These findings were subsequently confirmed by the low radioactivity found in the liver and kidney homogenates from rats sacrificed 10 min after i.p. administration. The analgesic activity of mono-and di-iodinated KTP-NH2 was also evaluated by a hot plate assay showing a delayed peak of maximal efficacy compared to KTP-NH2 (30 vs. 15 minutes). Overall, the peripheral effects of the peptides cannot be excluded.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease (2012)
Article in International Scientific Journal
Viña, D; Matos, MJ; Yáñez, M; Santana, L; Uriarte, E
Synthesis of coumarin-chalcone hybrids and evaluation of their antioxidant and trypanocidal properties (2013)
Article in International Scientific Journal
Vazquez Rodriguez, S; Figueroa Guíñez, R; Matos, MJ; Santana, L; Uriarte, E; Lapier, M; Maya, JD; Olea Azar, C
Progress in the development of small molecules as new human A(3) adenosine receptor ligands based on the 3-thiophenylcoumarin core (2016)
Article in International Scientific Journal
Klotz, KN; Fernanda Borges; Matos, MJ; Vilar, S; Kachler, S; Vazquez Rodriguez, S; Varela, C; Delogu, G; Hripcsak, G; Santana, L; Uriarte, E
PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity (2012)
Article in International Scientific Journal
Bianca Perez; Catia Teixeira; Ines S Albuquerque; Jiri Gut; Philip J Rosenthal; Miguel Prudencio; Paula Gomes
PRIMACENES: novel non-cytotoxic primaquine-ferrocene conjugates with anti-Pneumocystis carinii activity (2010)
Article in International Scientific Journal
Joana Matos; Nuno Vale; Margaret S Collins; Jiri Gut; Philip J Rosenthal; Melanie T Cushion; Rui Moreira; Paula Gomes

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-21 at 01:21:10 | Privacy Policy | Personal Data Protection Policy | Whistleblowing